Genetic evidence implicating natriuretic peptide receptor-3 in cardiovascular disease risk: a Mendelian randomization study.

Cronjé, Héléne T; Karhunen, Ville; Hovingh, G Kees; Coppieters, Ken; Lagerstedt, Jens O; Nyberg, Michael; Gill, Dipender

Cronjé, Héléne T; Karhunen, Ville; Hovingh, G Kees; Coppieters, Ken; Lagerstedt, Jens O; Nyberg, Michael; Gill, Dipender.

Affiliation

Cronjé HT; Department of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark. toinet.cronje@sund.ku.dk.
Karhunen V; Faculty of Science, Research Unit of Mathematical Sciences, University of Oulu, Oulu, Finland.
Hovingh GK; Research Unit of Population Health, Faculty of Medicine, University of Oulu, Oulu, Finland.
Coppieters K; Department of Vascular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Lagerstedt JO; Global Chief Medical Office, Novo Nordisk, Copenhagen, Denmark.
Nyberg M; Global Project Management, Global Drug Discovery, Novo Nordisk, Copenhagen, Denmark.
Gill D; Rare Endocrine Disorders, Research and Early Development, Novo Nordisk, Copenhagen, Denmark.

BMC Med ; 21(1): 158, 2023 04 26.

Article de En | MEDLINE | ID: mdl-37101178

Sujet(s)
Mots clés

Blood pressure; C-type natriuretic peptide; Cardiovascular disease; Genetic epidemiology; Mendelian randomization; NPR2; NPR3

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies cardiovasculaires / Accident vasculaire cérébral Type d'étude: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: BMC Med Sujet du journal: MEDICINA Année: 2023 Type de document: Article Pays d'affiliation: Danemark Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google